These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 16242277

  • 1. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
    Sweeney LG, Wang Z, Loebenberg R, Wong JP, Lange CF, Finlay WH.
    Int J Pharm; 2005 Nov 23; 305(1-2):180-5. PubMed ID: 16242277
    [Abstract] [Full Text] [Related]

  • 2. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H, Young PM, Chan HK, Agus H, Traini D.
    Eur J Pharm Sci; 2010 Jun 14; 40(3):239-47. PubMed ID: 20371286
    [Abstract] [Full Text] [Related]

  • 3. Effervescent dry powder for respiratory drug delivery.
    Ely L, Roa W, Finlay WH, Löbenberg R.
    Eur J Pharm Biopharm; 2007 Mar 14; 65(3):346-53. PubMed ID: 17156987
    [Abstract] [Full Text] [Related]

  • 4. Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals.
    Cipolla D, Wu H, Gonda I, Chan HK.
    J Aerosol Med Pulm Drug Deliv; 2015 Dec 14; 28(6):411-22. PubMed ID: 26469306
    [Abstract] [Full Text] [Related]

  • 5. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H, Teo J, Chew JW, Hadinoto K.
    Int J Pharm; 2016 Feb 29; 499(1-2):38-46. PubMed ID: 26757148
    [Abstract] [Full Text] [Related]

  • 6. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
    van Drooge DJ, Hinrichs WL, Dickhoff BH, Elli MN, Visser MR, Zijlstra GS, Frijlink HW.
    Eur J Pharm Sci; 2005 Oct 29; 26(2):231-40. PubMed ID: 16084699
    [Abstract] [Full Text] [Related]

  • 7. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS, Ng ML, Kho K, Hadinoto K.
    Int J Pharm; 2011 Feb 14; 404(1-2):289-300. PubMed ID: 21093560
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.
    Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, Fazeli MR, Jamalifar H.
    J Microencapsul; 2010 Feb 14; 27(7):618-27. PubMed ID: 20681747
    [Abstract] [Full Text] [Related]

  • 14. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS, Purewal TS, Alpar OH.
    J Control Release; 2009 Apr 17; 135(2):127-35. PubMed ID: 19059291
    [Abstract] [Full Text] [Related]

  • 15. Formation of ciprofloxacin nanocrystals within liposomes by spray drying for controlled release via inhalation.
    Khatib I, Tang P, Ruan J, Cipolla D, Dayton F, Blanchard JD, Chan HK.
    Int J Pharm; 2020 Mar 30; 578():119045. PubMed ID: 31981702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation.
    Khatib I, Khanal D, Ruan J, Cipolla D, Dayton F, Blanchard JD, Chan HK.
    Int J Pharm; 2019 Jul 20; 566():641-651. PubMed ID: 31202900
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.